BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4209135)

  • 41. Intermittent chemotherapy with trichlorfon (metrifonate) reverses proteinuria, hematuria, and leukocyturia in urinary schistosomiasis: results of a three-year field study.
    Doehring E; Feldmeier H; Dafalla AA; Ehrich JH; Vester U; Poggensee U
    J Infect Dis; 1984 Apr; 149(4):615-20. PubMed ID: 6725993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and mechanism of action of arachidonic acid in the treatment of hamsters infected with Schistosoma mansoni or Schistosoma haematobium.
    El Ridi R; Tallima H; Salah M; Aboueldahab M; Fahmy OM; Al-Halbosiy MF; Mahmoud SS
    Int J Antimicrob Agents; 2012 Mar; 39(3):232-9. PubMed ID: 22240411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantification of infection with Schistosoma haematobium in relation to epidemiology and selective population chemotherapy. II. Mass treatment with a single oral dose of metrifonate.
    Siongok TK; Ouma JH; Houser HB; Warren KS
    J Infect Dis; 1978 Dec; 138(6):856-8. PubMed ID: 739160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect on neuromuscular transmission of repeated administration of an organophosphorus compound, metrifonate, during treatment of children with urinary schistosomiasis.
    Maxwell IC; Le Quesne PM; Ekue JM; Biles JE
    Neurotoxicology; 1981 Dec; 2(4):687-701. PubMed ID: 6281697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metrifonate in schistosomiasis - therapy and prophylaxis.
    Jewsbury JM
    Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():123-30. PubMed ID: 7344406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical and sero-immunologic results of therapeutic trials of Ciba 32'644 Ba, carried out in 350 patients with chronic Schistosoma haematobium and Schistosoma mansoni bilharziasis].
    Gentilini M; Capron A; Le Parco JC; Vernes A; Biguet J; Domart A
    Bull Soc Pathol Exot Filiales; 1967; 60(3):241-63. PubMed ID: 5631075
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical development of oxamniquine in Egypt.
    Saif M; Gaber A
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):18-27, 134-43. PubMed ID: 7455504
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparison of the susceptibility to metrifonate of Schistosoma haematobium, S. mattheei and S. mansoni in hamsters.
    James C; Webbe G; Preston JM
    Ann Trop Med Parasitol; 1972 Dec; 66(4):467-74. PubMed ID: 4656447
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of endemic schistosomiasis and of hycanthone on the mental ability of African school children.
    Bell RM; Daly J; Kanengoni E; Jones JJ
    Trans R Soc Trop Med Hyg; 1973; 67(5):694-701. PubMed ID: 4779115
    [No Abstract]   [Full Text] [Related]  

  • 50. The oral treatment of urinary schistosomiasis in Egyptian patients with 'Oltipraz'.
    Abaza H; El-Kady A; Wasfy E
    Trop Geogr Med; 1984 Jun; 36(2):139-42. PubMed ID: 6474558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of metrifonate on hookworm infections in Kenyan children treated for urinary schistosomiasis. A preliminary report.
    Stephenson LS; Kurz KM; Latham MC; Kinoti S; Oduori ML
    East Afr Med J; 1982 Oct; 59(10):640-1. PubMed ID: 6892236
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical and therapeutic aspects of bilharziasis caused by Schistosoma mansoni].
    Janssens PG
    Acta Gastroenterol Belg; 1972; 35(10):427-67. PubMed ID: 4661970
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of schistosomiasis haematobium with metritionate in OPD-patients (author's transl)].
    Haas J; Hansen G; Jarrett B
    Immun Infekt; 1976 Aug; 4(4):162-7. PubMed ID: 1017847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epidemiological study of substitution of Schistosoma haematobium by Schistosoma mansoni in a schistosomiasis endemic area of West Africa, (Upper Volta) (author's transl)].
    Colette J; Sellin B; Garrigue G; Simonkovich E
    Med Trop (Mars); 1982; 42(3):289-96. PubMed ID: 7050612
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia.
    Wilkins HA; Moore PJ
    J Trop Med Hyg; 1987 Apr; 90(2):83-92. PubMed ID: 3104624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic evaluation of hycanthone in school children in rural endemic area in Egypt.
    Mousa AH; El-Abdin AZ; El-Garem AA; El-Raziky EH; Fadl AA
    Egypt J Bilharz; 1974; 1(1):65-83. PubMed ID: 4469236
    [No Abstract]   [Full Text] [Related]  

  • 57. [Results obtained on S. haematobium by Oltipraz in Niger (author's transl)].
    Rey JL; Sellin B; Simonkovich E; Charmot G
    Bull Soc Pathol Exot Filiales; 1982; 75(2):179-82. PubMed ID: 7105290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Field trials of ambilhar in the treatment of urinary bilharziasis in schoolchildren.
    Davis A
    Bull World Health Organ; 1966; 35(6):827-35. PubMed ID: 5298034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous use of a sensitive filtration technique and reagent strips in urinary schistosomiasis.
    Feldmeier H; Doehring E; Daffalla AA
    Trans R Soc Trop Med Hyg; 1982; 76(3):416-21. PubMed ID: 7112663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The modern treatment of bladder bilharziasis].
    Brunzema F
    Z Urol Nephrol; 1981 Nov; 74(11):837-8. PubMed ID: 7324593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.